Quality of blood pressure control and risk of cerebral bleeding in patients with oral anticoagulation

被引:4
作者
Huber, J
Stöllberger, C
Finsterer, J
Schneider, B
Länger, T
机构
[1] Hosp Rudolfstiftung, Dept Med 2, A-1030 Vienna, Austria
[2] Hosp Rosenhugel, Dept Neurol, Vienna, Austria
[3] Univ Vienna, Inst Med Stat & Documentat, A-1010 Vienna, Austria
[4] Austrian Res Ctr, Seibersdorf, Austria
关键词
arterial hypertension; cerebral bleeding; oral anticoagulation;
D O I
10.1046/j.1563-2571.2003.02048.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We assessed how many patients on long-term oral anticoagulation (OAC) (i) suffer from arterial hypertension (AH), (ii) are aware of AH, (iii) need improvement of their therapy and (iv) suffer from cerebral bleeding. Methods: Outpatients on long-term OAC were asked to measure blood pressure at least 4 times. Blood pressure was classified as normotensive if at least 75 % of all measurements were < 139/89 mm Hg; as mild/moderate AH if > 25 % of all measurements were 140 - 179 mm Hg systolic or 90 - 109 mm Hg diastolic; and as severe AH if > 25 % of all measurements were > 180 mm Hg systolic or > 110 mm Hg diastolic. Bleeding complications were registered. Results: Of the 235 patients (108 female, 67 +/- 12 years), 80 % suffered from AH. Severe AH was present in 5 %. Only 56 % were aware of suffering from AH. An improvement of antihypertensive therapy was needed in 64 %. Over 225 days, only one cerebral bleeding occurred. Blood pressure was normotensive in 30 % with known AH. Conclusions: Blood pressure control seems better in OAC patients than in normals, if the patient is aware of AH. Patients with AH on OAC are not aware of AH in > 50 %. Repeated blood pressure measurements in OAC are recommended, even if patients are not aware of AH.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 39 条
[1]   Underutilization of antithrombotic therapy in atrial fibrillation [J].
Adhiyaman, V ;
Kamalakannan, D ;
Oke, A ;
Shah, IU ;
White, AD .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2000, 93 (03) :138-140
[2]   Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals [J].
Albers, GW ;
Yim, JM ;
Belew, KM ;
Bittar, N ;
Hattemer, CR ;
Phillips, BG ;
Kemp, S ;
Hall, EA ;
Morton, DJ ;
Vlasses, PH .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (20) :2311-2316
[3]   Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals [J].
Albers, GW ;
Bittar, N ;
Young, L ;
Hattemer, CR ;
Gandhi, AJ ;
Kemp, SM ;
Hall, EA ;
Morton, DJ ;
Yim, J ;
Vlasses, PH .
NEUROLOGY, 1997, 48 (06) :1598-1604
[4]  
ALDERMAN M, 1999, J HYPERTENS, V17, P151
[5]   SURVEY OF USE OF ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION [J].
BATH, PMW ;
PRASAD, A ;
BROWN, MM ;
MACGREGOR, GA .
BRITISH MEDICAL JOURNAL, 1993, 307 (6911) :1045-1045
[6]   Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin [J].
Beyth, RJ ;
Quinn, LM ;
Landefeld, CS .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02) :91-99
[7]   Warfarin use among patients with atrial fibrillation [J].
Brass, LM ;
Krumholz, HM ;
Scinto, JM ;
Radford, M .
STROKE, 1997, 28 (12) :2382-2389
[8]  
Chesebro JH, 1996, ARCH INTERN MED, V156, P409
[9]   CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].
CONNOLLY, SJ ;
LAUPACIS, A ;
GENT, M ;
ROBERTS, RS ;
CAIRNS, JA ;
JOYNER, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355
[10]   ISCHEMIC AND HEMORRHAGIC STROKE IN PATIENTS ON ORAL ANTICOAGULANTS AFTER RECONSTRUCTION FOR CHRONIC LOWER-LIMB ISCHEMIA [J].
DAWSON, I ;
VANBOCKEL, JH ;
FERRARI, MD ;
VANDERMEER, FJM ;
BRAND, R ;
TERPSTRA, JL .
STROKE, 1993, 24 (11) :1655-1663